David Matthews nag-retweet

There's never been a disease-modifying drug for Parkinson's disease to slow its progression. Now there may be two emerging.
—GLP-1
nejm.org/doi/abs/10.105… @NEJM
—anti-synuclein antibody nature.com/articles/s4159…
@NatureMed

English










